This paper discusses why this is a particular moment for the NHS and Genomics England (GE), as they structure the commercial relationships with companies accessing the 100K Genomes database.

This report outlines the future of pharmacy - where these digital systems provide seamless, more customised clinical care and better medicine outcomes. It suggests that digital transformation will piece together Australia’s healthcare system and provide an unprecedented opportunity to increase the quality of patient care.

The Ministry of Health has opened public consultation on the proposals for the medicinal cannabis regulations needed to support the Medicinal Cannabis Scheme.

The opioid epidemic in North America has attracted considerable international concern because of the scale of the problem and the high rate of overdose deaths. This paper highlights the importance of being vigilant about the potential for similar problems in Australia, and continuing to monitor key indicators of opioid availability, use and harm.

Medical Affairs—a third strategic pillar for the pharmaceutical enterprise